Feb 22, 2018
Xencor Doses First Patient in Phase 1 Study of XmAb®18087 Bispecific Tumor Targeting Antibody for the Treatment of Neuroendocrine Tumors and Gastrointestinal Stromal Tumors
Feb 15, 2018
Global Neuroendocrine Tumors (NET) Market Report 2017: Novartis Leads Industry Sponsors with the Highest Number of Clinical Trials for NETs, Followed by Ipsen and Pfizer
Feb 13, 2018
Health Canada approves Ipsen's Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)
Jan 30, 2018
FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
Jan 26, 2018
FDA approves new treatment for certain digestive tract cancers
Nov 01, 2017
Today is Acromegaly Awareness Day
Oct 19, 2017
Clinical Data from Phase 1 PK/PD Study of Octreotide for Intranasal Delivery to be Presented at North American Neuroendocrine Tumor Society Symposium
Oct 04, 2017
Practitioners Get a Deeper Look at Stress and Adrenal Function From Precision Analytical, Inc.'s New Clinical Lab Test, the DUTCH Plus(TM) With Cortisol Awakening Response.
Sep 19, 2017
European Commission Approves XERMELO® (Telotristat Ethyl) For The Treatment Of Carcinoid Syndrome Diarrhea In Combination With Somatostatin Analog Therapy
Sep 18, 2017
Sex and Aggression Controlled Separately in Female Animal Brains, But Overlap in Males
Sep 07, 2017
Lexicon Pharmaceuticals Announces Four Data Presentations At The European Society Of Medical Oncology 2017 Congress
Sep 05, 2017
TransMedia Group to Boost Awareness of T Genix, America's Top Testosterone Booster
Jul 21, 2017
Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo® (Telotristat Ethyl)
Jun 19, 2017
NCCN Guidelines For Neuroendocrine Tumors Include XERMELO In Combination With Somatostatin Analog Therapy As A Recommended Treatment Option For Patients With Carcinoid Syndrome Diarrhea